Drug Approval | May 11, 2024
Strides receives USFDA approval for Sevelamer Carbonate Tablets
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
Receives 3 final and 2 tentative product approvals thus far in Q1FY25
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.8.29 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.615.82 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Investing in Malaysia's largest clinic operator to expand the healthcare business
Subscribe To Our Newsletter & Stay Updated
